MONITORING OF TNF-ALPHA BLOCKERS INFLIXIMAB AND ADALIMUMAB BY MEASURING TROUGH LEVEL CONCENTRATIONS AND ANTI-DRUG ANTIBODIES

被引：0
|
作者：
Westerlund, Johanna [1 ]
Jokiranta, T. Sakari [1 ,2 ]
机构：
[1] United Medix Labs Ltd, Espoo, Finland
[2] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2012年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [41] Adalimumab Serum Concentrations or Anti-Drug Antibodies Do Not Influence Fatigue in Patients with Crohn's Disease
    Karlsen, Lars Normann
    Carlsen, Arne
    Omdal, Roald
    Aabakken, Lars
    Bolstad, Nils
    Lundin, Knut
    Grimstad, Tore
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S44 - S45
  • [42] DETECTION OF TNFα BLOCKERS AND ANTI-DRUG'S ANTIBODIES LEVELS: A COMPARISON OF TWO COMMERCIALLY AVAILABLE ASSAYS
    Punceviciene, E.
    Arstikyte, I.
    Butrimiene, I.
    Venalis, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 880 - 880
  • [43] Relationship Between Adalimumab Concentrations, Plasma Cytokines, Anti-drug Antibodies and Disease Activity in Rheumatoid Arthritis
    Stamp, Lisa
    Keating, Paula
    Frampton, Christopher
    Barclay, Murray
    Fanning, Niamh
    Millier, Melanie
    Hessian, Paul
    O'Donnell, John
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [44] The first WHO reference panel for Infliximab anti-drug antibodies: a step towards harmonizing therapeutic drug monitoring
    Wadhwa, Meenu
    Cludts, Isabelle
    Atkinson, Eleanor
    Rigsby, Peter
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [45] Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting
    Moots, R. J.
    Xavier, Ricardo
    Mok, Chi Chiu
    Rahman, Mahboob U.
    Tsai, Wen-Chan
    Al Maini, Mustafa
    Pavelka, Karel
    Mahgoub, Ehab
    Kotak, Sameer
    Korth-Bradley, Joan
    Pedersen, Ronald
    Mele, Linda
    Shen, Qi
    Vlahos, Bonnie
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] UTILITY OF MEASURING ADALIMUMAB DRUG LEVELS AND ANTI-DRUG ANTIBODIES IN CLINICAL PRACTICE: A LARGE IBD REFERRAL CENTRE EXPERIENCE
    Warner, B. D.
    Johnston, E. L.
    Digby-Bell, J. L.
    Unsworth, N.
    Anderson, S.
    Sanderson, J. D.
    Arkir, Z.
    Irving, P. M.
    GUT, 2015, 64 : A93 - A93
  • [47] High level of anti-drug antibodies after intra-articular injection of anti-TNF
    Zufferey, Pascal
    Perreau, Mathieu
    So, Alexander
    RHEUMATOLOGY, 2015, 54 (12) : 2291 - 2292
  • [48] ANTI-DRUG ANTIBODIES (ADA): ASSAY PERFORMANCE IN PATIENTS TREATED FOR INFLAMMATORY BOWEL AND RHEUMATIC DISEASE WITH BIODRUGS, ADALIMUMAB AND INFLIXIMAB
    O'Donnell, J.
    Liu, J.
    Keating, P.
    Hock, B.
    Spellerberg, M.
    Barclay, M.
    Stamp, L.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 15 - 15
  • [49] Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
    Glintborg, B.
    Kringelbach, T.
    Bolstad, N.
    Warren, D. J.
    Eng, G.
    Sorensen, I. J.
    Loft, A. G.
    Hendricks, O.
    Hansen, I. M. J.
    Linauskas, A.
    Nordin, H.
    Kristensen, S.
    Lindegaard, H.
    Jensen, D. V.
    Goll, G. L.
    Hogdall, E.
    Gehin, J.
    Enevold, C.
    Nielsen, C. H.
    Krogh, N. S.
    Johansen, J. S.
    Hetland, M. L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (05) : 418 - 421
  • [50] Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA
    Toja-Camba, Francisco Jose
    Garcia-Quintanilla, Laura
    Rodriguez-Martinez, Lorena
    Tomine, Julia
    Cajade-Pascual, Francisco
    Feitosa, Carolina
    Zarra-Ferro, Irene
    Barreiro-De-Acosta, Manuel
    Gonzalez-Lopez, Jaime
    Mondelo-Garcia, Cristina
    Fernandez-Ferreiro, Anxo
    PHARMACEUTICS, 2023, 15 (11)
12345